» Articles » PMID: 35887320

Therapeutic Benefits of Selenium in Hematological Malignancies

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2022 Jul 27
PMID 35887320
Authors
Affiliations
Soon will be listed here.
Abstract

Supplementing chemotherapy and radiotherapy with selenium has been shown to have benefits against various cancers. This approach has also been shown to alleviate the side effects associated with standard cancer therapies and improve the quality of life in patients. In addition, selenium levels in patients have been correlated with various cancers and have served as a diagnostic marker to track the efficiency of treatments or to determine whether these selenium levels cause or are a result of the disease. This concise review presents a survey of the selenium-based literature, with a focus on hematological malignancies, to demonstrate the significant impact of selenium in different cancers. The anti-cancer mechanisms and signaling pathways regulated by selenium, which impart its efficacious properties, are discussed. An outlook into the relationship between selenium and cancer is highlighted to guide future cancer therapy development.

Citing Articles

Biosafety and pharmacokinetic characteristics of polyethylene pyrrolidone modified nano selenium in rats.

Li W, Lu X, Jiang L, Wang X BMC Biotechnol. 2024; 24(1):98.

PMID: 39609828 PMC: 11606190. DOI: 10.1186/s12896-024-00915-9.


50 Years of Organoselenium Chemistry, Biochemistry and Reactivity: Mechanistic Understanding, Successful and Controversial Stories.

Madabeni A, Bortoli M, Nogara P, Ribaudo G, Dalla Tiezza M, Flohe L Chemistry. 2024; 30(70):e202403003.

PMID: 39304519 PMC: 11639659. DOI: 10.1002/chem.202403003.


Concentration of serum trace elements in leukemia and lymphoma: A case-control study.

Rafieemehr H, Kamyari N, Maleki Behzad M Heliyon. 2024; 10(13):e33620.

PMID: 39040232 PMC: 11261077. DOI: 10.1016/j.heliyon.2024.e33620.


Antioxidant Metabolism Pathways in Vitamins, Polyphenols, and Selenium: Parallels and Divergences.

Andres C, Perez de la Lastra J, Juan C, Plou F, Perez-Lebena E Int J Mol Sci. 2024; 25(5).

PMID: 38473850 PMC: 10932048. DOI: 10.3390/ijms25052600.


Serum Trace Element Levels in Cancer Patients Undergoing Chemotherapy: a Before-After Analysis.

Rafieemehr H, Farmany A, Ghorbani S, Jafari M, Maleki Behzad M Biol Trace Elem Res. 2023; 202(10):4367-4374.

PMID: 38135818 DOI: 10.1007/s12011-023-04025-z.


References
1.
Almeida G, Rafique J, Saba S, Siminski T, Mota N, Wilhelm Filho D . Novel selenylated imidazo[1,2-a]pyridines for breast cancer chemotherapy: Inhibition of cell proliferation by Akt-mediated regulation, DNA cleavage and apoptosis. Biochem Biophys Res Commun. 2018; 503(3):1291-1297. DOI: 10.1016/j.bbrc.2018.07.039. View

2.
Chen Y, Prabhu K, Mastro A . Is selenium a potential treatment for cancer metastasis?. Nutrients. 2013; 5(4):1149-68. PMC: 3705340. DOI: 10.3390/nu5041149. View

3.
Li T, Pan S, Gao S, Xiang W, Sun C, Cao W . Diselenide-Pemetrexed Assemblies for Combined Cancer Immuno-, Radio-, and Chemotherapies. Angew Chem Int Ed Engl. 2019; 59(7):2700-2704. DOI: 10.1002/anie.201914453. View

4.
Toubhans B, Gazze S, Bissardon C, Bohic S, Gourlan A, Gonzalez D . Selenium nanoparticles trigger alterations in ovarian cancer cell biomechanics. Nanomedicine. 2020; 29:102258. DOI: 10.1016/j.nano.2020.102258. View

5.
Last K, Maharaj L, Perry J, Strauss S, Fitzgibbon J, Lister T . The activity of methylated and non-methylated selenium species in lymphoma cell lines and primary tumours. Ann Oncol. 2006; 17(5):773-9. DOI: 10.1093/annonc/mdl004. View